for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Banca Farmafactoring SpA

BFF.MI

Latest Trade

5.33EUR

Change

-0.08(-1.48%)

Volume

447,708

Today's Range

5.27

 - 

5.40

52 Week Range

4.37

 - 

5.73

As of on the Italian SE (Mercato Continuo Italia) ∙ Minimum 15 minute delay

Pricing

Previous Close
5.41
Open
5.40
Volume
447,708
3M AVG Volume
9.56
Today's High
5.40
Today's Low
5.27
52 Week High
5.73
52 Week Low
4.37
Shares Out (MIL)
170.49
Market Cap (MIL)
922.33
Forward P/E
9.44
Dividend (Yield %)
9.09

Next Event

Banca Farmafactoring SpA Annual Shareholders Meeting

Latest Developments

More

BFF Banking Group 9-Month Net Profit Up At EUR 60.1 Mln

BFF Banking Group Places Unsecured Senior Preferred Bond For EUR 300 Mln

BFF Banking Group To Issue Up To EUR 300 Mln Reg-S Preffered Bond

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Banca Farmafactoring SpA

Banca Farmafactoring SpA is an Italy-based company primarily engaged in the corporate financial services. The Company specializes in managing and selling receivables due the National Health Service and the Public Administration. Its service portfolio comprises: credit management, debt recovery, business accounting, online invoicing, non-recourse factoring, as well as factoring with recourse, among others. It also offers online banking products, such as deposit accounts. The Company operates in Italy, Spain, Portugal, Poland, Czech Republic, and Slovak Republic. The Company operates through subsidiaries: Farmafactoring Espana SA, Farmafactoring SPV I Srl and the companies of the Magellan Group.

Industry

Consumer Financial Services

Contact Info

Via Domenichino, 5

+39.02.49905458

http://www.bancafarmafactoring.it/

Executive Leadership

Salvatore Messina

Non-Executive Independent Chairman of the Board

Massimiliano Belingheri

Chief Executive Officer, Executive Director

Luigi Sbrozzi

Non-Executive Vice Chairman of the Board

Carlo Maurizio Zanni

Financial Reporting Officer

Ben Carlton Langworthy

Non-Executive Director

Key Stats

2.00 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2017

0.2K

2018

0.2K

2019(E)

0.2K
EPS (EUR)

2017

0.490

2018

0.542

2019(E)

0.573
Price To Earnings (TTM)
10.02
Price To Sales (TTM)
4.59
Price To Book (MRQ)
2.73
Price To Cash Flow (TTM)
9.36
Total Debt To Equity (MRQ)
230.37
LT Debt To Equity (MRQ)
230.37
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-BFF Banking Group: New Lock-up By Certain Managers Of Banca Farmafactoring S.p.A.

* BFF LUXEMBOURG S.À R.L. ENTERED WITH CEO OF BANCA FARMAFACTORING S.P.A. AND OTHER SIX MANAGERS IN LOCK-UP AGREEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Banca Farmafactoring Secondary ABO Orders Below €5.75 Per Share Risk Missing - Bookrunner

* BLOCK TRADE - BANCA FARMAFACTORING S.P.A.: BOOKRUNNER SAYS SECONDARY ABO ORDERS BELOW €5.75 PER SHARE RISK MISSING

BRIEF-Banca Farmafactoring Secondary Accelerated Bookbuilt Offering ‍Books - Bookrunner

* BLOCK TRADE - BANCA FARMAFACTORING S.P.A.: BOOKRUNNER SAYS SECONDARY ACCELERATED BOOKBUILT OFFERING BOOKS ARE COVERED, PRICE GUIDANCE TO FOLLOW Further company coverage:

BRIEF-Banca Farmafactoring 9-month net profit up at EUR 68.3 mln

* 9-MONTH NET PROFIT EUR 68.3 MILLION VERSUS EUR 41.0 MILLION A YEAR AGO

BRIEF-Banca Farmafactoring completes first acquisition of receivables in Greece

* COMPLETES ACQUISITION OF PORTFOLIO OF CREDITS TOWARDS PUBLIC HOSPITALS IN GREECE

BRIEF-Banca Farmafactoring H1 net profit up at EUR 50.7 mln

* H1 NET PROFIT EUR 50.7 MILLION VERSUS EUR 28.3 MILLION YEAR AGO

BRIEF-Banca Farmafactoring places 200 mln euro unsecured bond due 2022

* ANNOUNCES PLACEMENT TO INSTITUTIONAL INVESTORS OF SENIOR UNSECURED AND UNRATED BOND DUE JUNE 2022, FOR AGGREGATE NOMINAL AMOUNT OF EUR 200 MILLION

BRIEF-Banca Farmafactoring Q1 net income up at EUR 34.2 mln

* REPORTED NET INCOME OF €34.2 MLN IN 1Q17, VERSUS € 15.3 MLN IN 1Q16

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up